Long-term follow-up of bone density, general and reproductive health in female survivors after treatment for haematological malignancies

European Journal of Haematology

Volumn 93, Issue 2, 2014, Pages 137-142

  Naessén, Sabine ^a   Bergström, Ingrid ^b   Ljungman, Per ^a   Landgren, Britt Marie ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Bone mineral density; Fertility preservation; Haematological malignancy; Haematological stem cell transplantation; Hormone replacement theory; Premature ovarian failure

Indexed keywords

PARATHYROID HORMONE; CALCIUM; MYELOABLATIVE AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BONE DENSITY; CANCER SURVIVOR; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; FEMALE; FEMALE FERTILITY; FERTILITY PRESERVATION; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MYELOABLATIVE CONDITIONING; NONHODGKIN LYMPHOMA; OOCYTE DONATION; OVARY FUNCTION; OVERALL SURVIVAL; PARATHYROID HORMONE BLOOD LEVEL; PARTHENOGENESIS; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; WHOLE BODY RADIATION; ALLOTRANSPLANTATION; AUTOTRANSPLANTATION; BLOOD; DRUG EFFECTS; FERTILITY; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TEST; IMMUNOSUPPRESSIVE TREATMENT; LIVE BIRTH; LONGITUDINAL STUDY; NEWBORN; PATHOLOGY; PHYSIOLOGY; PREMENOPAUSE; PROCEDURES; RADIATION RESPONSE;

ADULT; BONE DENSITY; CALCIUM; FEMALE; FERTILITY; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HORMONE REPLACEMENT THERAPY; HUMANS; INFANT, NEWBORN; LIVE BIRTH; LONGITUDINAL STUDIES; MYELOABLATIVE AGONISTS; PARATHYROID HORMONE; PREMENOPAUSE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 84904285979     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12317     Document Type: Article

References (33)

1. Schover LR, Rybicki LA, Martin BA, Bringelsen KA. Having children after cancer. A pilot survey of survivors' attitudes and experiences. Cancer 1999;86:697-709.
2. Pansini F, Albertazzi P, Bonaccorsi G, Calisesi M, Campobasso C, Zanotti L, Bagni B, Mollica G. The menopausal transition: a dynamic approach to the pathogenesis of neurovegetative complaints. Eur J Obstet Gynecol Reprod Biol 1994;57:103-9.
3. Rivkees SA, Crawford JD. The relationship of gonadal activity and chemotherapy-induced gonadal damage. JAMA 1988;259:2123-5.
4. Ratts VS, Flaws JA, Kolp R, Sorenson CM, Tilly JL. Ablation of bcl-2 gene expression decreases the numbers of oocytes and primordial follicles established in the post-natal female mouse gonad. Endocrinology 1995;136:3665-8.
5. Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Exp Oncol 1996;14:1718-29.
6. Warne GL, Fairley KF, Hobbs JB, Martin FI. Cyclophosphamide-induced ovarian failure. N Engl J Med 1973;29:1159-62.
7. Lie Fong S, Laven JS, Hakvoort-Cammel FG, Schipper I, Visser JA, Themmen AP, de Jong FH, van den Heuvel-Eibrink MM. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone. Hum Reprod 2009;24:982-90.
8. Oktay K, Sonmezer M, Barad D, Gleicher N. Trying to reduce ovarian damage in patients with Hodgkin lymphoma using GnRH agonists? Fertil Steril 2009;91:298-9.
9. Kang MI, Lee WY, Oh KW, Han JH, Song KH, Cha BY, Lee KW, Son HY, Kang SK, Km CC. The short-term changes of bone mineral metabolism following bone marrow transplantation. Bone 2000;26:275-9.
10. Buchs N, Helg C, Collao C, Chapuis B, Slosman D, Bonjour JP, Rizzoli R. Allogeneic bone marrow transplantation is associated with a preferential femoral neck bone loss. Osteoporos Int 2001;12:880-6.
11. Letizia C, Celi M, Iori AP, Verrelli C, Caliumi C, Diacinti D, Arcese W, D'Erasmo E. Bone mass, bone metabolism, and prevalence of spinal fractures in recipients of allogenic bone marrow transplantation for leukemia. Ann Ital Med Int 2004;19:175-83.
12. Kerchan-Schindl K, Mitterbauer M, Füreder W, Kudlacek S, Grampp S, Bieglmayer C, Fialka-Moser V, Pietschmann P, Kalhs P. Bone metabolism in patients more than five years after bone marrow transplantation. Bone Marrow Transplant 2004;34:491-6.
13. Yao S, McCarthy PL, Dunford LM, et al. High prevalence of early-onset osteopenia/osteoporosis after allogeneic stem cell transplantation and improvement after bisphosphonate therapy. Bone Marrow Transplant 2008;41:393-8.
14. Ebeling PR. Metabolic bone diseases: translational research-preventing fractures with denosumab. Nat Rev Rheumatol 2009;5:660-1.
15. Finkelstein JS, Brockwell SE, Mehta V, et al. Bone mineral density changes during the menopause transition in a multiethnic cohort of women. J Clin Endocrinol Metab 2008;93:861-8.
16. Tomkinson A, Reeve J, Shaw RW, Noble BS. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab 1997;82:3128-35.
17. Törring O, Albertsson D, Ljunggren Ö. Rubbningar I Kalciumomsättningen - Osteoporos Och Frakturprevention. Stockholm: Läkemedelsboken; 2011:608-27.
18. Park K, Ju WC, Yeo JH, Kim JY, Seo HS, Uchida Y, Cho Y. Increased OPG/RANKL ratio in the conditioned medium of soybean-treated osteoblasts suppresses RANKL-induced osteoclast differentiation. Int J Mol Med 2014;33:178-84.
19. Ganguly S, Divine CL, Aljitawi OS, Abhyankar S, McGuirk JP, Graves L. Prophylactic use of zoledronic acid to prevent early bone loss is safe and feasible in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation. Clin Transplant 2012;26:447-53.
20. Stevenson JC. Prevention of osteoporosis: one step forward, two steps back. Menopause Int 2011;17:137-41.
21. Stein E, Ebeling P, Shane E. Post-transplantation osteoporosis. Endocrinol Metab Clin North Am 2007;36:937-63.
22. Zanchetta MB, Diehl M, Buttazzoni M, Galich A, Silveira F, Bogado CE, Zanchetta JR. Assessment of bone microarchitecture in postmenopausal women on long term bisphosphonate therapy with atypical fractures of the femur. J Bone Miner Res 2014;29:999-1004.
23. Ballaschk A, Kalaitzis N, Röpke M, Piatek S. Atypical femoral fractures in bisphosphonate therapy. Unfallchirurg 2013; 113-013-2526-7.
24. Gonsalves A, Carrier M, Wells PS, McDiarmid SA, Huebsch LB, Allan DS. Incidence of symptomatic venous thromboembolism following hematopoietic stem cell transplantation. J Thromb Haemost 2008;6:1468-73.
25. Kansu E. Thrombosis in stem cell transplantation. Hematology 2012;17(Suppl 1):S159-62.
26. Barbui T, Finazzi G, Falanga A. Myeloproliferative neoplasms and thrombosis. Blood 2013;122:2176-84.
27. Meirow D. Reproduction post-chemotherapy in young cancer patients. Mol Cell Endocrinol 2000;169:123-31.
28. Sanders JE, Buckner CD, Amos D, Levy W, Appelbaum FR, Doney K, Storb R, Sullivan KM, Witherspoon RP, Thomas ED. Ovarian function following marrow transplantation for aplastic anemia or leukaemia. J Clin Oncol 1988;6:813-8.
29. Schmidt KL, Andersen CY, Loft A, Byskov AG, Ernst E, Andersen AN. Follow-up of ovarian function post-chemotherapy following ovarian cryopreservation and transplantation. Hum Reprod 2005;20:3539-46.
30. Oktay K, Newton H, Aubard Y, Salha O, Gosden RG. Cryopreservation of immature human oocytes and ovarian tissue: an emerging technology? Fertil Steril 1998;69:1-7.
31. Oktay K, Karlikaya G. Ovarian function after transplantation of frozen, banked autologous ovarian tissue. N Engl J Med 2000;342:1919.
32. Callejo J, Salvador C, Miralles A, Vilaseca S, Lailla JM, Balasch J. Long-term ovarian function evaluation after autografting by implantation with fresh and frozen-thawed human ovarian tissue. J Clin Endocrinol Metab 2001;86:4489-94.
33. Yeomanson DJ, Morgan S, Pacey AA. Discussing fertility preservation at the time of cancer diagnosis: dissatisfaction of young females. Pediatr Blood Cancer 2013;60:1996-2000.